Navigation Links
Chromosomal variations found in early passage female embryonic stem cells

Human embryonic stem cells hold great promise for studying and treating disease and for the practice of regenerative medicine. However, more must be learned to ensure the cells that may one day be transplanted into humans are safe.

In one of many safety-related studies going on worldwide, scientists at the UCLA Broad Stem Cell Research Center have uncovered that variations in X chromosome inactivation take place in very early passages of female human embryonic stem cells lines, information that will play an important role in ensuring the safety of cells grown for therapeutic use and a discovery that also may have implications in the development of cancer.

Chromosomal and genetic variations found in human embryonic stem cells lines have been attributed, in large part, to the various culture conditions in which they're grown, said Tamar Dvash, first author of the study and a postdoctoral fellow at UCLA.

However, the work by the Broad Stem Cell Research Center scientists reveals that very early in their growth, female human embryonic stem cells already show variation in the inactivation of the X chromosome.

"It suggests that culture conditions and methods in the derivation of human embryonic stem cells could be further improved to achieve a uniform pattern of X chromosome inactivation," said Guoping Fan, an associate professor of human genetics and senior author of the study.

The study is published June 25, 2010 in the early online edition of the journal PLoS ONE, a publication of the Public Library of Science.

All female cells have two X chromosomes and in early development, one X chromosome is permanently inactivated. The X chromosome inactivation ensures that females, like males, have one functional copy of the X chromosome in each body cell and that the cells develop normally. If the second X chromosome is not inactivated, the result could be disease development, including some cancers in which two active X chromosomes can be found in the malignant cells, Dvash said.

Previously, what scientists knew about human embryonic development was gleaned from studying mouse embryos. However, the advent of human embryonic stem cell research has allowed researchers to closely study early human development. Dvash, Fan and other scientists, including collaborator Neta Lavon of Cedars-Sinai Medical Center, were examining the process of inactivation of the X chromosome when they made their observation.

The creation of a stem cell line includes many steps. The donated, frozen blastocysts are thawed and the inner cell mass the 20 to 50 cells that are fully pluripotent in the blastocyst - is placed in culture with cells that support its growth. After a time, a small piece of the developing stem cell colony, or group of cells, is cut away and placed into a culture dish to further expand, a process called passaging.

The cells studied by Dvash and Fan were passaged only five to ten times instead of the usual more than 20 times, meaning the culture in which they were grown should have had less influence on any variation found in the cells. However, even at the first five passages, the resulting cells showed variations in X chromosome inactivation, meaning some cells had inactivated one X chromosome and some had not.

"People are looking at these cells as having great potential for transplantation and possible cures for diseases," Dvash said. "What this study proves is that we need to monitor X chromosome inactivation closely in cells being considered for therapeutic use. We need to make sure they're undergoing normal inactivation to ensure they will be stable when they begin to differentiate."

Going forward, the scientists will also examine induced pluripotent stem cells, adult stem cells that have been reprogrammed to have all the qualities of embryonic stem cells, which can become any cell in the body. They will study skin cells taken from females, which would already have undergone inactivation of one X chromosome because they are already differentiated. The cells will be programmed into embryonic-like cells with two active X chromosomes so they can more closely study the process of inactivation.

"We want to know how does it happen and when," Dvash said.


Contact: Kim Irwin
University of California - Los Angeles

Related medicine news :

1. Sonic Hedgehog variations linked to recurrence, survival and response to therapy of bladder cancer
2. New figures on cancer in Europe show a steady decline in mortality but big variations
3. Genetic variations indicate risk of recurrence, secondary cancer among head and neck cancer patients
4. 9-country study shows wide variations in how women with early breast cancer are treated
5. Three Genes Linked to Variations in Eye Color
6. Sebastian Ferrero Foundation and Shands HealthCare Have Selected Sg2 to Conduct a Needs Assessment for a Gainesville-Based Childrens Hospital
7. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
8. One5 Foundation Launches National Haitian Relief Campaign with TShirtAds
9. Acupuncture found effective against depression during pregnancy
10. Welch Foundation honors Orth as rising star in chemistry
11. The National Christian Foundation Offers to Match Gifts to Haiti
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... all, Water For Empowerment ™ attracts volunteers together who want to combine ... empowering women as key stakeholders in the process. The non-profit launched its first ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the traditional and far-infrared ... traditional and far-infrared saunas. , For traditional saunas, Finnleo is offering ... sauna wood, and Finnleo uses only European Grade A Nordic White Spruce from sustainably ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... direct sauna parts and accessories. , Sauna accessories help improve the bather experience ... and personality. From basic styles for the purist looking for simplicity in design ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, ... Union (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, civil ... for the opening of the 5th African Network for Drugs and Diagnostics Innovation, ...
(Date:11/25/2015)... TX (PRWEB) , ... November 25, 2015 , ... For ... the companies’ “ Two Organizations, One Beat ” campaign. The partnership between the two ... services to aid in MAP International’s cause. , MAP International was founded in 1954 ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the Global Cell Surface Testing Market: ... report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... --> ... att använda SyMRI för att hitta optimal ... med multipel skleros (MS) eller hjärntumörmetastaser och ... för att kunna använda SyMRI Research Edition ... kan man generera flera konstrastbilder från en ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
Breaking Medicine Technology: